probenecid has been researched along with Hearing Loss in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobs, C | 1 |
| Kaubisch, S | 1 |
| Halsey, J | 1 |
| Lum, BL | 1 |
| Gosland, M | 1 |
| Coleman, CN | 1 |
| Sikic, BI | 1 |
1 trial available for probenecid and Hearing Loss
| Article | Year |
|---|---|
The use of probenecid as a chemoprotector against cisplatin nephrotoxicity.
Topics: Adult; Aged; beta 2-Microglobulin; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Drug Eva | 1991 |